Glenmark Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on October 30, 2014, to consider and approve the Company’s Unaudited Financial Statements for the Second Quarter/Half year ended September 30, 2014 (Q2). Further, as per the ‘Code of Conduct for Prevention of Insider Trading' of the Company, the trading window shall remain closed for Directors and other designated employees of the Company from October 17, 2014 to October 31, 2014 for the purpose of approval of Unaudited Financial Results for the Second Quarter/Half year ended September 30, 2014.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: